Roivant Sciences Ltd (ROIV)
NASDAQ · Healthcare
Roivant Sciences Ltd EBITDA 2021–2026
Roivant Sciences Ltd annual/quarterly ebitda history and growth rate from 2022 to 2025. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Roivant Sciences Ltd ebitda for the quarter ending June 30, 2025 was -283.8 M, a 191.54% increase year-over-year.
- Roivant Sciences Ltd ebitda for the twelve months ending June 30, 2025 was -931.4 M.
- Roivant Sciences Ltd annual ebitda for 2026 was -511.7 M, a 48.27% decrease from 2025.
- Roivant Sciences Ltd annual ebitda for 2025 was -989.2 M, a 121.89% decrease from 2024.
- Roivant Sciences Ltd annual ebitda for 2024 was 4.5 B, a 608.96% decrease from 2023.
- Roivant Sciences Ltd annual ebitda for 2023 was -887.9 M.
EBITDA
TRAILING 12 MONTHS · $B
QUARTERLY · $B
Roivant Sciences Ltd EBITDA — FAQ
Roivant Sciences Ltd (ROIV) ebitda over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ROIV's ebitda history?
The chart and table above show Roivant Sciences Ltd's ebitda by year and by quarter, including the growth rate.